Identification of novel B-1 transitional progenitors by B-1 lymphocyte fate-mapping transgenic mouse model Bhlhe41dTomato-Cre

Author:

Li Hui,Tang Yangyang,Ren Jinfeng,Bai Ruixue,Hu Lang,Jia Wenyu,Cao Yiwei,Hong Li,Xu Meizhen,Gao Sijia,Shi Yanbiao,Pan Shuai,Wang Liang,Zheng Kuiyang,Zhao Shuli,Wang Hui

Abstract

B-1 lymphocytes exhibit specialized roles in host defense against multiple pathogens. Despite the fact that CD19+CD93+B220lo/-B cells have been identified as B-1 progenitors, the definition for B-1 progenitors remains to be elucidated as CD19+CD93+B220+B cells are capable to give rise to B-1 cells. Given that transcription factor Bhlhe41 is highly and preferentially expressed in B-1 cells and regulates B-1a cell development, we generated a transgenic mouse model,Bhlhe41dTomato-Cre, for fate mapping and functional analysis of B-1 cells.Bhlhe41dTomato-Cremice efficiently traced Bhlhe41 expression, which was mainly restricted to B-1 cells in B-cell lineage. We showed an efficient and specific Cre-mediated DNA recombination in adult B-1 cells and neonatal B-1 progenitors rather than B-2 cells by flow cytometric analysis ofBhlhe41dTomato-Cre/+Rosa26EYFPmice. Treatment ofBhlhe41dTomato-Cre/+Rosa26iDTRmice with diphtheria toxin revealed a robust efficacy of B-1 cell depletion. Interestingly, usingBhlhe41dTomato-Cremice, we demonstrated that neonatal B-1 progenitors (CD19+CD93+B220lo/-) expressed Bhlhe41 and were identical to well-defined transitional B-1a progenitors (CD19+CD93+B220lo/-CD5+), which only gave rise to peritoneal B-1a cells. Moreover, we identified a novel population of neonatal splenic CD19hidTomato+B220hiCD43loCD5loB cells, which differentiated to peritoneal B-1a and B-1b cells.Bhlhe41deficiency impaired the balance between CD19hidTomato+B220lo/-CD5hiand CD19hidTomato+B220hiCD5locells. Hence, we identified neonatal CD19hidTomato+B220hiCD43loCD5loB cells as novel transitional B-1 progenitors.Bhlhe41dTomato-Cre/+mouse can be used for fate mapping and functional studies of B-1 cells in host-immune responses.

Funder

National Natural Science Foundation of China

Jiangsu Provincial Special Program of Clinical Medical Science

Xuzhou Science and Technology Program

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3